Net Deals Web Search

Search results

1. Results From The WOW.Com Content Network

2. Drugs You Don't Need For Disorders You Don't Have - The ...

   highline.huffingtonpost.com/articles/en/sleep...

   Under pressure from lobbyists and Capitol Hill, the FDA in 1997 produced new guidelines declaring that companies’ ads just had to devote roughly equal time to the risks and benefits of a drug. One year later, spending on television drug ads had more than doubled, from $310 million to $664 million.

3. Doxylamine - Wikipedia

   en.wikipedia.org/wiki/Doxylamine

   Doxylamine succinate is the active ingredient in many over-the-counter sleep-aids branded under various names. Doxylamine succinate and pyridoxine (Vitamin B6) are the ingredients of Diclegis, approved by the FDA in April 2013 becoming the only drug approved for morning sickness [ 46 ] with a class A safety rating for pregnancy (no evidence of ...

4. Sleep apnea - Wikipedia

   en.wikipedia.org/wiki/Sleep_apnea

   The "Pillar" device is a treatment for snoring and obstructive sleep apnea; it is thin, narrow strips of polyester. Three strips are inserted into the roof of the mouth (the soft palate) using a modified syringe and local anesthetic, in order to stiffen the soft palate. This procedure addresses one of the most common causes of snoring and sleep ...

5. Obstructive sleep apnea - Wikipedia

   en.wikipedia.org/wiki/Obstructive_sleep_apnea

   Obstructive sleep apnea ( OSA) is the most common sleep-related breathing disorder and is characterized by recurrent episodes of complete or partial obstruction of the upper airway leading to reduced or absent breathing during sleep. These episodes are termed "apneas" with complete or near-complete cessation of breathing, or "hypopneas" when ...

6. New treatment for ‘slow killer’ sleep apnoea in hospital trial

   www.aol.com/treatment-slow-killer-sleep-apnoea...

   For premium support please call: 800-290-4726 more ways to reach us

7. Axsome's sleep disorder drug succeeds in late-stage trial ...

   www.aol.com/news/axsome-therapeutics-sleep...

   (Reuters) -Axsome Therapeutics said on Monday its experimental therapy cut the frequency of disruptive episodes of muscle weakness tied to a sleep disorder called narcolepsy in a late-stage trial.